Cargando…
Unlocking the therapeutic potential of primary tumor-draining lymph nodes
Lymph nodes draining the primary tumor are essential for the initiation of an effective anti-tumor T-cell immune response. However, cancer-derived immune suppressive factors render the tumor-draining lymph nodes (TDLN) immune compromised, enabling tumors to invade and metastasize. Unraveling the dif...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805797/ https://www.ncbi.nlm.nih.gov/pubmed/30944963 http://dx.doi.org/10.1007/s00262-019-02330-y |
_version_ | 1783461477378686976 |
---|---|
author | Rotman, Jossie Koster, Bas D. Jordanova, Ekaterina S. Heeren, A. Marijne de Gruijl, Tanja D. |
author_facet | Rotman, Jossie Koster, Bas D. Jordanova, Ekaterina S. Heeren, A. Marijne de Gruijl, Tanja D. |
author_sort | Rotman, Jossie |
collection | PubMed |
description | Lymph nodes draining the primary tumor are essential for the initiation of an effective anti-tumor T-cell immune response. However, cancer-derived immune suppressive factors render the tumor-draining lymph nodes (TDLN) immune compromised, enabling tumors to invade and metastasize. Unraveling the different mechanisms underlying this immune escape will inform therapeutic intervention strategies to halt tumor spread in early clinical stages. Here, we review our findings from translational studies in melanoma, breast, and cervical cancer and discuss clinical opportunities for local immune modulation of TDLN in each of these indications. |
format | Online Article Text |
id | pubmed-6805797 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-68057972019-11-05 Unlocking the therapeutic potential of primary tumor-draining lymph nodes Rotman, Jossie Koster, Bas D. Jordanova, Ekaterina S. Heeren, A. Marijne de Gruijl, Tanja D. Cancer Immunol Immunother Focussed Research Review Lymph nodes draining the primary tumor are essential for the initiation of an effective anti-tumor T-cell immune response. However, cancer-derived immune suppressive factors render the tumor-draining lymph nodes (TDLN) immune compromised, enabling tumors to invade and metastasize. Unraveling the different mechanisms underlying this immune escape will inform therapeutic intervention strategies to halt tumor spread in early clinical stages. Here, we review our findings from translational studies in melanoma, breast, and cervical cancer and discuss clinical opportunities for local immune modulation of TDLN in each of these indications. Springer Berlin Heidelberg 2019-04-03 2019 /pmc/articles/PMC6805797/ /pubmed/30944963 http://dx.doi.org/10.1007/s00262-019-02330-y Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Focussed Research Review Rotman, Jossie Koster, Bas D. Jordanova, Ekaterina S. Heeren, A. Marijne de Gruijl, Tanja D. Unlocking the therapeutic potential of primary tumor-draining lymph nodes |
title | Unlocking the therapeutic potential of primary tumor-draining lymph nodes |
title_full | Unlocking the therapeutic potential of primary tumor-draining lymph nodes |
title_fullStr | Unlocking the therapeutic potential of primary tumor-draining lymph nodes |
title_full_unstemmed | Unlocking the therapeutic potential of primary tumor-draining lymph nodes |
title_short | Unlocking the therapeutic potential of primary tumor-draining lymph nodes |
title_sort | unlocking the therapeutic potential of primary tumor-draining lymph nodes |
topic | Focussed Research Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805797/ https://www.ncbi.nlm.nih.gov/pubmed/30944963 http://dx.doi.org/10.1007/s00262-019-02330-y |
work_keys_str_mv | AT rotmanjossie unlockingthetherapeuticpotentialofprimarytumordraininglymphnodes AT kosterbasd unlockingthetherapeuticpotentialofprimarytumordraininglymphnodes AT jordanovaekaterinas unlockingthetherapeuticpotentialofprimarytumordraininglymphnodes AT heerenamarijne unlockingthetherapeuticpotentialofprimarytumordraininglymphnodes AT degruijltanjad unlockingthetherapeuticpotentialofprimarytumordraininglymphnodes |